Lisinopril formulations
US11179434B2 · kind B2 · utility
3Cited by
31References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2021 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Mar 5, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.